Investor's Daily
Investor's Daily
  • Home
  • About Us
    Contributors Help and Contact
  • Topics
  • Free Reports
vaccine, covid 19, pandemic, AstraZeneca, Pfizer
EU

The Vaccine Wars should surprise nobody. Neither will the consequences.

person Nickolai Hubble
schedule 2 February 2021
Last week, the Vaccine Wars began. Who could’ve seen it coming? Actually, the stoush over the AstraZeneca vaccine should surprise nobody. Nor the EU’s outrage…
covid 19, mutations, pandemic, Sweden
Gold & Commodities

Mutation: the makings of a never-ending crisis

person Nickolai Hubble
schedule 28 January 2021
Sweden has closed its border to Norway over the discovery of a Covid-19 mutation. It’s an ironic reversal of the past situation. The “British Virus,”…
covid, pandemic, inflation
EU

The PCR test Casedemic

person Nickolai Hubble
schedule 27 January 2021
Are PCR tests the true source of the pandemic? Can adjusting the tests save us from Covid-19? That’s the question we dig into today. But…
covid, pandemic, Brexiteers, Brexit
Stocks

Why Britain will boom after Covid-19

person Nickolai Hubble
schedule 19 January 2021
The world is increasingly divided. Into the hads and had nots. The nations that had widespread Covid-19 outbreaks and those that didn’t. As horrific as…
Brexit, Europe, Covic-19, vaccine, Corona
EU

Boris’ Covid-19 report card for 2020

person Nickolai Hubble
schedule 7 January 2021
Yesterday’s Fortune & Freedom article, The Brexit that time will forget, didn’t win many friends. But it’s not our job to tell you what you…

Get ahead of the curve with Investor's Daily

Enter your email to access exclusive insights and stay informed with our Investor's Daily daily email.

Because Investor's Daily is completely free, we do have to fund it with advertising. Occasionally we will send you promotional emails, which will contain advertisements from us. By signing up to our free emails, you are consenting to receive these promotions. However we will never give, sell or rent your email address to any other companies. If you want to stop receiving our free emails at any time, you can immediately unsubscribe by clicking on the link in each email. For more information, please see our privacy policy.

Contact Info

Click here to contact us

Cookies & Policies

Terms and Conditions Privacy Policy Complaints Procedure Cookie Policy Whitelisting

Although Southbank Investment Research Ltd, the publisher of Investor's Daily is regulated by the Financial Conduct Authority, the editorial content in Investor's Daily is not regulated by the Financial Conduct Authority. The editorial content is for general information only; it gives no advice on investments and is not intended to be relied upon by individual readers in making (or not making) specific investment decisions. Appropriate independent advice should be obtained before making any such decision.

From time to time we may tell you about other information services published by Southbank Investment Research Limited which do contain content which is regulated by the FCA. When viewing that regulated content, you should review the risk warnings accompanying it.

© 2025 Southbank Investment Research Ltd. Registered in England and Wales No 9539630. VAT No GB629 7287 94. Registered Office: Basement, 95 Southwark Street, London SE1 0HXN. Authorised and regulated by the Financial Conduct Authority. FCA No 706697. https://register.fca.org.uk.

Southbank Investment Research AI Collision
0203 5142 487